DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 1 filers reported holding DOVA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $359,000 | +97.3% | 12,827 | -0.8% | 0.00% | – |
| Q2 2019 | $182,000 | +34.8% | 12,927 | -14.7% | 0.00% | – |
| Q1 2019 | $135,000 | +16.4% | 15,154 | -1.2% | 0.00% | – |
| Q4 2018 | $116,000 | -47.3% | 15,343 | +46.1% | 0.00% | – |
| Q3 2018 | $220,000 | -34.7% | 10,500 | -6.7% | 0.00% | -100.0% |
| Q2 2018 | $337,000 | – | 11,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,125,851 | $23,693,000 | 0.90% |
| Broadfin Capital, LLC | 351,800 | $2,667,000 | 0.35% |
| Birchview Capital, LP | 40,000 | $303,000 | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 185,000 | $1,402,000 | 0.16% |
| Fosun International Ltd | 261,780 | $1,984,000 | 0.12% |
| Spark Investment Management LLC | 61,100 | $463,000 | 0.03% |
| Candriam S.C.A. | 233,200 | $1,768,000 | 0.03% |
| GW&K Investment Management, LLC | 178,536 | $1,353,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 20,613 | $156,000 | 0.01% |
| Point72 Hong Kong Ltd | 1,456 | $11,000 | 0.01% |